Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 12, 2017
PKC-dependent regulation of Kv7.5 channels by the bronchoconstrictor histamine in human airway smooth muscle cellsJennifer M Haick, Lioubov I Brueggemann, Leanne L Cribbs, et al.The Journal of Biological Chemistry|December 4, 2013
Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channelsLioubov I Brueggemann, Alexander R Mackie, Leanne L Cribbs, et al.Hypertension (Dallas, Tex. : 1979)|July 27, 2011
Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculaturePernille B Hansen, Christian B Poulsen, Steen Walter, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 31, 2006
Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cellsLioubov I Brueggemann, Christopher J Moran, John A Barakat, et al.Molecular Pharmacology|December 25, 2015
Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 CurrentsBharath K Mani, Christina Robakowski, Lyubov I Brueggemann, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|January 21, 2014
KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airwaysLioubov I Brueggemann, Jennifer M Haick, Samantha Neuburg, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2011
Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapyLioubov I Brueggemann, Priyanka P Kakad, Robert B Love, et al.The Journal of Pharmacology and Experimental Therapeutics|February 15, 2008
Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistanceAlexander R Mackie, Lioubov I Brueggemann, Kyle K Henderson, et al.Molecular Pharmacology|February 21, 2002
Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channelsGuido Michels, Jan Matthes, Renate Handrock, et al.Science (New York, N.Y.)|November 25, 2003
Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channelsChien-Chang Chen, Kathryn G Lamping, Daniel W Nuno, et al.Pageof 3